Replies to post #306109 on Elite Pharmaceuticals Inc (ELTP)

[meshcan]

Good times ahead!

[YJ4LIFE]

Best time to add more to my big account. Good luck king!

[pgp419]

You were right on the money with the Generic Adderall approval date. Hope you are right again with this one. GLTAL

[no2koolaid]

Nice summary of the future wins set for Elite and its shareholders...

OBTW: Following the Adcom vote, the FDA made it official today...

The FDA’s reluctance with prescription painkillers at a time the United States is swept by a tsunami of opioid abuse, overdose and addiction was on full display on Wednesday, when the regulator rejected Mallinckrodt’s $MNK abuse-deterrent opioid painkiller, soliciting more data from the UK drugmaker.

The drug under scrutiny was a tweaked version of Roxicodone, an immediate-release formulation of the commonly abused opioid oxycodone that was approved by the FDA in 2000. This reformulation was designed to deter abuse via snorting or injecting. In its CRL, the agency “provided guidance regarding areas of further evaluation necessary to resubmit the NDA for further review,” Mallinckrodt said.

[NASDAQ2020]

$2.oo by SequestOx

[jour_trader]

All great stuff, but Elite has to prove both on the top like and bottom line. ADFs are not selling well, so SequestOx may have minimal impact if it can’t sell. Isradipine could fall either way.

Elite needs to execute on Sungen relationship and this will take time to see how good of a sales distribution arm Sungen can create.

Bad thing is there will be minimal lift for Q3 financials. May also be same for Q4 unless Norco/Perc & Aderall can be partnered & launched as well in fiscal Q4.